Calgene Corporation

Monsanto Technology LLC

Arcadia Biosciences, Inc.

Other

Global Clean Energy Holdings, Inc

Christine K Shewmaker

Vic C Knauf

William R Hiatt

David M Stalker

Jean C Kridl

Daniel Facciotti

Alison Van Eenennaam

Janette V Oakes

Donald Emlay

Eric Rey

Frank Flider

Ganesh M Kishore

Sekhar S Boddupalli

Shaukat H Rangwala

B Ganesh Bhat

Renata F Ditt

Ann R Pokalsky

Raymond E Sheehy

Carolyn Hutcheon

Mylavaraapu Venkatramesh

Frank J Flider

The present invention provides isolated FAD2 and FAE1 genes and FAD2 and FAE1 protein sequences ofspecies, e.g.,, mutations inFAD2 and FAE1 genes, and methods of using the same. In addition, methods of alteringseed composition and/or improvingseed oil quality are disclosed. Furthermore, methods of breedingcultivars and/or other closely related species to produce plants having altered or improved seed oil and/or meal quality are provided.

[object Object]

The present invention relates to compositions and methods for preparing gamma-linoleic acid (GLA) in safflower plants, particularly from seeds of safflower. Nucleic acid sequences and constructs encoding one or more fatty acid desaturase sequences are used to generate transgenic safflower plants that contain and express one or more of these sequences and produce high levels of GLA in safflower seeds. Provided are transgenic safflower plants and seeds that produce high levels of GLA. Additionally provided are oils produced from seeds of this invention. The invention also relates to methods of treating a variety of diseases including nervous system disorders, inflammatory conditions, cancer and cardiovascular disorders using the oils of this invention.

Safflower with elevated gamma-linolenic acid

The present invention relates to compositions and methods for preparing gamma-linoleic acid (GLA) in safflower plants, particularly from seeds of safflower. Nucleic acid sequences and constructs encoding one or more fatty acid desaturase sequences are used to generate transgenic safflower plants that contain and express one or more of these sequences and produce high levels of GLA in safflower seeds. Provided are transgenic safflower plants and seeds that produce high levels of GLA.

The present invention is directed to nucleic acid molecules and nucleic acid constructs, and other agents associated with simultaneous up- and down-regulation of expression of RNAs. Specifically it includes methods of simultaneously enhancing the expression of a first RNA at the same time as suppressing the expression of a second RNA. The present invention also specifically provides constructs capable of simultaneously enhancing the expression of a first RNA while at the same time suppressing the expression of a second RNA, methods for utilizing such agents and plants containing such agents. The present invention also provides other constructs including polycistronic constructs.

Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs

Methods are provided for producing plants and seeds having altered carotenoid, fatty acid and tocopherol compositions. The methods find particular use in increasing the carotenoid levels in oilseed plants and in providing desirable high oleic acid seed oils.

Methods for producing carotenoid compounds and specialty oils in plant seeds

Novel DNA constructs are provided which are functional in soybean plants and provide for expression in soybean plant cells. Particularly, the constructs include a promoter region, as exemplary, the soybean small subunit of ribulose-1,5-bisphosphate carboxylase, an endogenous or exogenous gene other than the normal structural gene associated with the promoter, and a sequence for integration into the plant genome, such as Ri- or Ti-plasmid.

Transformation system with Ti or Ri plasmid

Methods are provided for producing plants and seeds having altered carotenoid, fatty acid and tocopherol compositions. The methods find particular use in increasing the carotenoid and tocopherol levels in oilseed plants, and in providing desirable high oleic acid seed oils.

Methods for producing carotenoid compounds, tocopherol compounds, and specialty oils in plant seeds

The present invention is directed to the modification of reserve polysaccharides in plants. Specifically, it has been found that host plants can be successfully transformed with a nucleic acid sequence capable of expressing a chimeric reserve polysaccharide modification enzyme gene sequence which will synthesize novel reserve polysaccharides in plants or convert the transformed plant's endogenous starch reserves to novel starch degradation products.

Glycogen biosynthetic enzymes in plants

Methods for producing carotenoid compounds, and specialty oils in plant seeds

Modification of soluble solids in fruit using sucrose phosphate synthase

This invention relates to methods for the utilization of sucrose phosphate synthase encoding sequences to modify the soluble solids in plant sink tissue. The method permits an increase in the sweetness of tomato fruit.

Soluble solids modification using sucrose phosphate synthase encoding

Regulation of expression of genes encoded for in plant cell genomes is achieved by integration of a gene under the transcriptional control of a promoter which is functional in the host and in which the transcribed strand of DNA is complementary to the strand of DNA that is transcribed from the endogenous gene(s) one wishes to regulate. The integrated gene, referred to as antisense, provides an RNA sequence capable of binding to naturally existing RNAs, exemplified by polygalacturonase, and inhibiting their expression, where the anti-sense sequence may bind to the coding, non-coding, or both, portions of the RNA. The antisense construction may be introduced into the plant cells in a variety of ways and be integrated into the plant genome for inducible or constitutive transcription of the antisense sequence. A wide variety of plant cell properties may be modified by employing this technique.

Growing community of inventors

Woodland, CA, United States of America

Christine K Shewmaker